RSS

NHS England

Gay and bisexual men are facing significant issues when trying to access trial placements for PrEP medication, new research shows. Read more

News

After years of negotiations, NHS England has signed an agreement with Vertex Pharmaceuticals to make the company’s suite of cystic fibrosis medicines available to patients in England. Read more

News

Simon Stevens.jpg

Twocoms / Shutterstock.com

A new gene therapy which restores sight will be provided by the NHS, chief executive Simon Stevens has announced. Read more

News

NHS England is funding a new drug to treat people with a genetic disorder where they can bleed severely. Read more

News

The NHS will fast-track new tumour targeting cancer drugs in an effort to lead the way in personalised medicines. Read more

News

NHS England has announced a landmark deal, giving children and young people access to Novartis’ Kymriah (a chimeric antigen receptor T-cell, CAR-T, therapy) — a personalised therapy for the treatment of cancer. Read more

News

Swedish Orphan Biovitrum (Sobi) — a pharmaceutical company that specialises in rare diseases — has secured NHS England reimbursement for its medicine for the management of urea cycle disorders (UCDs), Ravicti (glycerol phenylbutyrate). Read more

News

NHS England has set out its plans to simplify research processes enabling clinical trials to be fast-tracked and improving patient access. Read more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

The House of Lords Science and Technology Committee will question NHS England on the life sciences and industrial strategy as a part of its ongoing inquiry tomorrow (Tuesday 13 March). Read more

News

Researchers from the University of Oxford in collaboration with an intellectual property law firm have revealed that the NHS may be able to recoup over half a billion pounds from Pfizer if its Supreme Court patent appeal is unsuccessful Read more

News

NHS England initiative, SBRI Healthcare, has revealed which companies will benefit from its investment of £8.7 million — aimed at advancing the development of novel technologies to future-proof primary care and GP services. Read more

News

NHS England has called on the pharma industry to work with them on an ambitious plan to eliminate hepatitis C throughout the country five years earlier than the World Health Organisation’s (WHO’s) goal of 2030. Read more

News

NHS England has revealed that thousands of patients have benefited from the new CDF and as a result of discounts it has secured on eight treatments, savings of around £140 million should be generated over the course of the next five years Read more

News

Global pharmaceutical company, Mylan, is joining in the battle to prevent HIV infection by delivering the world’s biggest pre-exposure prophylaxis (PrEP) implementation trial, which will target an estimated 10,000 high risk people. Read more

News

NHS England’s funded programme, Small Business Research Initiative (SBRI) Healthcare, has been recognised as ‘the best role model’ in an independent review by David Connell. Read more

News

Patients in England will now have immediate access to the new multiple sclerosis (MS) treatment, cladribine tablets (Mavenclad), thanks to a commercial agreement between the manufacturer, Merck, and NHS England that has been announced today. Read more

News

A new statement has been released based on a decision of the Board of the Association of the British Pharmaceutical Industry (ABPI) that it will not appeal the outcome of its judicial review application versus NICE Read more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

Speaking at Expo conference in Manchester, the head of NHS England, Simon Stevens, unveiled an ambitious plan for the NHS as it approaches its 70th anniversary. Read more

News